Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-054367

PORTOLA PHARMACEUTICALS INC · PTLA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Tao Fu
Officer — EVP, CBO
Period of report
Jun 16, 2015
Accepted (ET)
Jun 17, 2015 · 7:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jun 15, 2015A2,500$0.00A2,500D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2$44.39Jun 15, 2015A140,000A—Jun 15, 2025Common Stock140,000140,000D
Performance Stock UnitF3—Jun 15, 2015A25,000A—Jan 15, 2019Common Stock25,00025,000D

Explanation of responses